{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,28]],"date-time":"2026-10-28T17:35:16Z","timestamp":1793208916237,"version":"4.5.0"},"reference-count":55,"publisher":"MDPI AG","issue":"18","license":[{"start":{"date-parts":[[2021,9,21]],"date-time":"2021-09-21T00:00:00Z","timestamp":1632182400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Cancers"],"abstract":"<jats:p>Background: HIV-infected patients now have long life expectation since the introduction of the highly active antiretroviral therapy (HAART). Liver diseases, especially cirrhosis and hepatocellular carcinoma (HCC), currently represent a leading cause of death in this setting of patients. Aim: To address the results of liver transplantation (LT) for HCC in HIV-infected patients. Methods: All patients with and without HIV infection who underwent LT for HCC (n = 420) between 2001 and 2021 in our center were analyzed with the intent of comparing graft and patient survival. Cox regression analysis was used to determine prognostic survival factors and logistic regression to determine the predictor factors of post-LT recurrence. Results: Among 1010 LT, 32 were HIV-infected recipients. With an average follow-up of 62 \u00b1 51 months, 5-year overall survival in LT recipients with and without HIV-infection was 71.6% and 69.9%, respectively (p = ns), whereas 5-year graft survival in HIV-infected and HIV-non infected was 68.3% and 68.2%, respectively (p = ns). The independent predictive factor of survival in the study group was: HCV infection (HR 1.83, p = 0.024). There were no significant differences in the pathological characteristics of HCC between the two groups. The logistic regression analysis of the study population demonstrated that microvascular invasion (HR 5.18, p&lt; 0.001), HCC diameter (HR 1.16, p = 0.028), and number of HCC nodules (HR 1.26, p = 0.003) were predictors of recurrence post-LT. Conclusion: Our study shows that HIV patients undergoing LT for HCC have comparable results in terms of post-LT survival. Excellent results can be achieved for HIV-infected patients with HCC, as long as a strategy of close surveillance and precise treatment of the tumor is adopted while on the waiting list.<\/jats:p>","DOI":"10.3390\/cancers13184727","type":"journal-article","created":{"date-parts":[[2021,9,21]],"date-time":"2021-09-21T22:34:01Z","timestamp":1632263641000},"page":"4727","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":14,"title":["Liver Transplantation for HCC in HIV-Infected Patients: Long-Term Single-Center Experience"],"prefix":"10.3390","volume":"13","author":[{"given":"Gian Piero","family":"Guerrini","sequence":"first","affiliation":[{"name":"Hepato-Pancreato-Biliary Surgery and Liver Transplantation Unit, University of Modena and Reggio Emilia, Azienda Ospedaliero-Universitaria di Modena, 41125 Modena, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Massimiliano","family":"Berretta","sequence":"additional","affiliation":[{"name":"Infectious Diseases Unit, Department of Clinical and Experimental Medicine, University of Messina, 98122 Messina, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giovanni","family":"Guaraldi","sequence":"additional","affiliation":[{"name":"Infectious Diseases Unit, Department of Surgical, Medical, Dental and Morphological Sciences, University of Modena and Reggio Emilia, Azienda Ospedaliero-Universitaria di Modena, 41125 Modena, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8326-069X","authenticated-orcid":false,"given":"Paolo","family":"Magistri","sequence":"additional","affiliation":[{"name":"Hepato-Pancreato-Biliary Surgery and Liver Transplantation Unit, University of Modena and Reggio Emilia, Azienda Ospedaliero-Universitaria di Modena, 41125 Modena, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1021-4419","authenticated-orcid":false,"given":"Giuseppe","family":"Esposito","sequence":"additional","affiliation":[{"name":"Hepato-Pancreato-Biliary Surgery and Liver Transplantation Unit, University of Modena and Reggio Emilia, Azienda Ospedaliero-Universitaria di Modena, 41125 Modena, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roberto","family":"Ballarin","sequence":"additional","affiliation":[{"name":"Hepato-Pancreato-Biliary Surgery and Liver Transplantation Unit, University of Modena and Reggio Emilia, Azienda Ospedaliero-Universitaria di Modena, 41125 Modena, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Valentina","family":"Serra","sequence":"additional","affiliation":[{"name":"Hepato-Pancreato-Biliary Surgery and Liver Transplantation Unit, University of Modena and Reggio Emilia, Azienda Ospedaliero-Universitaria di Modena, 41125 Modena, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefano","family":"Di Sandro","sequence":"additional","affiliation":[{"name":"Hepato-Pancreato-Biliary Surgery and Liver Transplantation Unit, University of Modena and Reggio Emilia, Azienda Ospedaliero-Universitaria di Modena, 41125 Modena, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fabrizio","family":"Di Benedetto","sequence":"additional","affiliation":[{"name":"Hepato-Pancreato-Biliary Surgery and Liver Transplantation Unit, University of Modena and Reggio Emilia, Azienda Ospedaliero-Universitaria di Modena, 41125 Modena, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2021,9,21]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1056\/NEJMp1916753","article-title":"Four Decades of HIV\/AIDS\u2014Much Accomplished, Much to Do","volume":"383","author":"Fauci","year":"2020","journal-title":"N. Engl. J. Med."},{"key":"ref_2","first-page":"3619","article-title":"Clinical presentation and outcome of non-AIDS defining cancers, in HIV-infected patients in the ART-era: The Italian Cooperative Group on AIDS and tumors activity","volume":"19","author":"Berretta","year":"2015","journal-title":"Eur. Rev. Med. Pharmacol. Sci."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1056\/NEJMra1615896","article-title":"HIV-Associated Cancers and Related Diseases","volume":"378","author":"Yarchoan","year":"2018","journal-title":"N. Engl. J. Med."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1002\/hep.29115","article-title":"Risk of end-stage liver disease, hepatocellular carcinoma, and liver-related death by fibrosis stage in the hepatitis C Alaska Cohort","volume":"66","author":"Bruden","year":"2017","journal-title":"Hepatology"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"e93","DOI":"10.1016\/S2352-3018(18)30295-9","article-title":"Contributions of traditional and HIV-related risk factors on non-AIDS-defining cancer, myocardial infarction, and end-stage liver and renal diseases in adults with HIV in the USA and Canada: A collaboration of cohort studies","volume":"6","author":"Althoff","year":"2019","journal-title":"Lancet HIV"},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1245\/s10434-007-9559-5","article-title":"Liver transplantation for hepatocellular carcinoma","volume":"15","author":"Mazzaferro","year":"2008","journal-title":"Ann. Surg. Oncol."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"e26","DOI":"10.1200\/JCO.2006.06.1374","article-title":"Don\u2019t deny liver transplantation to HIV patients with hepatocellular carcinoma in the highly active antiretroviral therapy era","volume":"24","author":"Berretta","year":"2006","journal-title":"J. Clin. Oncol."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1007\/s11904-019-00460-7","article-title":"HIV and Solid Organ Transplantation: Where Are we Now","volume":"16","author":"Botha","year":"2019","journal-title":"Curr. HIV\/AIDS Rep."},{"key":"ref_9","first-page":"190","article-title":"Liver and kidney transplantation in HIV-infected patients","volume":"11","author":"Frassetto","year":"2009","journal-title":"AIDS Rev."},{"key":"ref_10","first-page":"e2073","article-title":"Influence of Social Determinants of Health on Timeliness to Treatment for Metastatic HCC and the Impact of Affordable Care Act","volume":"8","author":"Jayakrishnan","year":"2021","journal-title":"World Cancer Res. J."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"1258","DOI":"10.1634\/theoncologist.2010-0400","article-title":"Hepatocellular carcinoma in HIV-infected patients: Check early, treat hard","volume":"16","author":"Berretta","year":"2011","journal-title":"Oncologist"},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1097\/CCO.0b013e328355e0d7","article-title":"Malignancy in the HIV-infected patients undergoing liver and kidney transplantation","volume":"24","author":"Nissen","year":"2012","journal-title":"Curr. Opin. Oncol."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1016\/j.transproceed.2015.12.049","article-title":"Solid Organ Transplantation in HIV+ Recipients: Italian Experience","volume":"48","author":"Morabito","year":"2016","journal-title":"Transplant. Proc."},{"key":"ref_14","doi-asserted-by":"crossref","unstructured":"(2018). EASL Clinical Practice Guidelines: Management of hepatocellular carcinoma. J. Hepatol., 69, 182\u2013236.","DOI":"10.1016\/j.jhep.2018.03.019"},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1002\/hep.29086","article-title":"AASLD guidelines for the treatment of hepatocellular carcinoma","volume":"67","author":"Heimbach","year":"2018","journal-title":"Hepatology"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"2587","DOI":"10.1111\/j.1600-6143.2007.01965.x","article-title":"Liver transplantation for hepatocellular carcinoma: Validation of the UCSF-expanded criteria based on preoperative imaging","volume":"7","author":"Yao","year":"2007","journal-title":"Am. J. Transplant."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1053\/j.gastro.2017.09.025","article-title":"Metroticket 2.0 Model for Analysis of Competing Risks of Death After Liver Transplantation for Hepatocellular Carcinoma","volume":"154","author":"Mazzaferro","year":"2018","journal-title":"Gastroenterology"},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"2552","DOI":"10.1111\/ajt.13408","article-title":"A Multistep, Consensus-Based Approach to Organ Allocation in Liver Transplantation: Toward a \u201cBlended Principle Model\u201d","volume":"15","author":"Cillo","year":"2015","journal-title":"Am. J. Transplant."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"e2087","DOI":"10.1002\/rcs.2087","article-title":"Full robotic ALPPS for HCC with intrahepatic portal vein thrombosis","volume":"16","author":"Assirati","year":"2020","journal-title":"Int. J. Med. Robot."},{"key":"ref_20","doi-asserted-by":"crossref","unstructured":"Magistri, P., Catellani, B., Frassoni, S., Guidetti, C., Olivieri, T., Assirati, G., Caporali, C., Pecchi, A., Serra, V., and Ballarin, R. (2020). Robotic Liver Resection Versus Percutaneous Ablation for Early HCC: Short- and Long-Term Results. Cancers, 12.","DOI":"10.3390\/cancers12123578"},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"1142","DOI":"10.1002\/lt.24169","article-title":"Downstaging hepatocellular carcinoma: A systematic review and pooled analysis","volume":"21","author":"Parikh","year":"2015","journal-title":"Liver Transplant."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"1968","DOI":"10.1002\/hep.27752","article-title":"Downstaging of hepatocellular cancer before liver transplant: Long-term outcome compared to tumors within Milan criteria","volume":"61","author":"Yao","year":"2015","journal-title":"Hepatology"},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1002\/1097-0142(195405)7:3<462::AID-CNCR2820070308>3.0.CO;2-E","article-title":"Primary carcinoma of the liver: A study of 100 cases among 48,900 necropsies","volume":"7","author":"Edmondson","year":"1954","journal-title":"Cancer"},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"1937","DOI":"10.1016\/j.transproceed.2008.06.001","article-title":"Temporary porto-caval shunt utility during orthotopic liver transplantation","volume":"40","author":"Arzu","year":"2008","journal-title":"Transplant. Proc."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1097\/TP.0b013e3181c7dcc0","article-title":"First report on a series of HIV patients undergoing rapamycin monotherapy after liver transplantation","volume":"89","author":"Montalti","year":"2010","journal-title":"Transplantation"},{"key":"ref_26","first-page":"779","article-title":"A Simplified HAART Regimen with Raltegravir and Lamivudine, and Pharmacokinetic Interactions with a Combined Immunosuppressive Therapy with Tacrolimus and Everolimus in an HIV\/HCV\/HBV\/HDV Patient after Liver Transplantation","volume":"63","author":"Cirioni","year":"2014","journal-title":"West Indian Med. J."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"12311","DOI":"10.3748\/wjg.v21.i43.12311","article-title":"Role of liver transplantation in human immunodeficiency virus positive patients","volume":"21","author":"Joshi","year":"2015","journal-title":"World J. Gastroenterol."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"S39","DOI":"10.1002\/lt.20261","article-title":"Liver transplantation in patients with HIV infection","volume":"10","author":"Fung","year":"2004","journal-title":"Liver Transplant."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"1965","DOI":"10.1016\/j.transproceed.2008.05.067","article-title":"Human immunodeficiency virus and liver transplantation: Our point of view","volume":"40","author":"Berretta","year":"2008","journal-title":"Transplant. Proc."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1055\/s-0032-1316474","article-title":"Liver transplantation in HIV patients","volume":"32","author":"Fox","year":"2012","journal-title":"Semin Liver Dis."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1002\/lt.22329","article-title":"Liver transplantation in human immunodeficiency virus-positive patients","volume":"17","author":"Joshi","year":"2011","journal-title":"Liver Transplant."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1097\/TP.0000000000000829","article-title":"Long-term Outcomes After Liver Transplantation Among Human Immunodeficiency Virus-Infected Recipients","volume":"100","author":"Locke","year":"2016","journal-title":"Transplantation"},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"2078","DOI":"10.1097\/TP.0000000000003107","article-title":"Temporal Trends and Outcomes in Liver Transplantation for Recipients With HIV Infection in Europe and United States","volume":"104","author":"Dodge","year":"2020","journal-title":"Transplantation"},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"71","DOI":"10.3389\/fphar.2016.00071","article-title":"Drug-Drug Interactions Based on Pharmacogenetic Profile between Highly Active Antiretroviral Therapy and Antiblastic Chemotherapy in Cancer Patients with HIV Infection","volume":"7","author":"Berretta","year":"2016","journal-title":"Front. Pharmacol."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1111\/j.1600-6143.2007.02061.x","article-title":"HIV-infected liver and kidney transplant recipients: 1- and 3-year outcomes","volume":"8","author":"Roland","year":"2008","journal-title":"Am. J. Transplant."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1097\/MOT.0000000000000199","article-title":"Hepatitis C virus-HIV-coinfected patients and liver transplantation","volume":"20","author":"Kardashian","year":"2015","journal-title":"Curr. Opin. Organ. Transplant."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/j.cld.2010.09.012","article-title":"HIV infection and the liver: The importance of HCV-HIV coinfection and drug-induced liver injury","volume":"15","author":"Merwat","year":"2011","journal-title":"Clin. Liver Dis."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"2513","DOI":"10.1111\/ajt.14996","article-title":"Direct-acting antivirals are effective and safe in HCV\/HIV-coinfected liver transplant recipients who experience recurrence of hepatitis C: A prospective nationwide cohort study","volume":"18","author":"Manzardo","year":"2018","journal-title":"Am. J. Transplant."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1002\/hep.29642","article-title":"Hepatitis C and human immunodeficiency virus coinfection in the era of direct-acting antiviral agents: No longer a difficult-to-treat population","volume":"67","author":"Sikavi","year":"2018","journal-title":"Hepatology"},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1056\/NEJMoa1501315","article-title":"Ledipasvir and Sofosbuvir for HCV in Patients Coinfected with HIV-1","volume":"373","author":"Naggie","year":"2015","journal-title":"N. Engl. J. Med."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1007\/s15010-016-0976-x","article-title":"Cirrhosis and liver transplantation in patients co-infected with HIV and hepatitis B or C: An observational cohort study","volume":"45","author":"Childs","year":"2017","journal-title":"Infection"},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"14192","DOI":"10.18632\/oncotarget.13929","article-title":"Serum and tissue markers in hepatocellular carcinoma and cholangiocarcinoma: Clinical and prognostic implications","volume":"8","author":"Berretta","year":"2017","journal-title":"Oncotarget"},{"key":"ref_43","first-page":"3421","article-title":"Multimodal oncological approach in patients affected by recurrent hepatocellular carcinoma after liver transplantation","volume":"21","author":"Guerrini","year":"2017","journal-title":"Eur. Rev. Med. Pharmacol. Sci."},{"key":"ref_44","doi-asserted-by":"crossref","unstructured":"Biondi, A., Malaguarnera, G., Vacante, M., Berretta, M., D\u2019Agata, V., Malaguarnera, M., Basile, F., Drago, F., and Bertino, G. (2012). Elevated serum levels of Chromogranin A in hepatocellular carcinoma. BMC Surg., 12.","DOI":"10.1186\/1471-2482-12-S1-S7"},{"key":"ref_45","first-page":"e1537","article-title":"Hepatitis b virus infection and hepatocellular carcinoma in plwh: Epidemiology, pathogenesis and treatment","volume":"7","author":"Rullo","year":"2020","journal-title":"World Cancer Res. J."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1093\/jnci\/djz214","article-title":"HIV RNA, CD4+ Percentage, and Risk of Hepatocellular Carcinoma by Cirrhosis Status","volume":"112","author":"Torgersen","year":"2020","journal-title":"J. Natl. Cancer Inst."},{"key":"ref_47","first-page":"1257","article-title":"Hepatocellular carcinoma in HIV positive patients","volume":"16","author":"Nunnari","year":"2012","journal-title":"Eur. Rev. Med. Pharmacol. Sci."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"2285","DOI":"10.1097\/00002030-200411190-00009","article-title":"Hepatocellular carcinoma in HIV-infected patients: Epidemiological features, clinical presentation and outcome","volume":"18","author":"Puoti","year":"2004","journal-title":"AIDS"},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1016\/j.jhep.2007.06.010","article-title":"Presentation and outcome of hepatocellular carcinoma in HIV-infected patients: A U.S.-Canadian multicenter study","volume":"47","author":"Fox","year":"2007","journal-title":"J. Hepatol."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1016\/j.ejso.2007.05.004","article-title":"Hepatocellular carcinoma in HIV patients treated by liver transplantation","volume":"34","author":"Berretta","year":"2008","journal-title":"Eur. J. Surg. Oncol."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1634\/theoncologist.2012-0255","article-title":"Multicenter italian experience in liver transplantation for hepatocellular carcinoma in HIV-infected patients","volume":"18","author":"Tarantino","year":"2013","journal-title":"Oncologist"},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1002\/hep.24062","article-title":"Liver transplantation for hepatocellular carcinoma: The impact of human immunodeficiency virus infection","volume":"53","author":"Vibert","year":"2011","journal-title":"Hepatology"},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"1136","DOI":"10.1097\/TP.0000000000003174","article-title":"Liver Transplantation for Hepatocellular Carcinoma. Working Group Report from the ILTS Transplant Oncology Consensus Conference","volume":"104","author":"Mehta","year":"2020","journal-title":"Transplantation"},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"2077","DOI":"10.1002\/hep.28643","article-title":"The extended Toronto criteria for liver transplantation in patients with hepatocellular carcinoma: A prospective validation study","volume":"64","author":"Sapisochin","year":"2016","journal-title":"Hepatology"},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1016\/j.suronc.2015.09.003","article-title":"Predictive value of nodule size and differentiation in HCC recurrence after liver transplantation","volume":"25","author":"Guerrini","year":"2016","journal-title":"Surg. Oncol."}],"container-title":["Cancers"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2072-6694\/13\/18\/4727\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T07:02:58Z","timestamp":1760166178000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2072-6694\/13\/18\/4727"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,9,21]]},"references-count":55,"journal-issue":{"issue":"18","published-online":{"date-parts":[[2021,9]]}},"alternative-id":["cancers13184727"],"URL":"https:\/\/doi.org\/10.3390\/cancers13184727","relation":{},"ISSN":["2072-6694"],"issn-type":[{"value":"2072-6694","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,9,21]]}}}